You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Therapeutic targeting of EPH receptors and their ligands
|
|---|---|
| Published in |
Nature Reviews Drug Discovery, December 2013
|
| DOI | 10.1038/nrd4175 |
| Pubmed ID | |
| Authors |
Andrew W. Boyd, Perry F. Bartlett, Martin Lackmann |
| Abstract |
Critical roles for EPH receptor (EPH)-ephrin signalling in a range of chronic and regenerative diseases are increasingly being recognized. In particular, the complex roles of EPHs and ephrins in tumour growth and progression, and in nerve injury and regeneration have been studied extensively. This has led to considerable progress in developing strategies for their therapeutic targeting, with some anticancer agents already in clinical trials. Promising leads for non-malignant diseases are also emerging, with compelling preclinical data encouraging clinical development. We discuss this rapidly developing area of drug discovery, highlighting the associated challenges and limitations. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 256 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 3 | 1% |
| United States | 3 | 1% |
| Singapore | 1 | <1% |
| Brazil | 1 | <1% |
| Japan | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 246 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 67 | 26% |
| Student > Ph. D. Student | 59 | 23% |
| Student > Master | 22 | 9% |
| Student > Bachelor | 22 | 9% |
| Student > Doctoral Student | 18 | 7% |
| Other | 34 | 13% |
| Unknown | 34 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 76 | 30% |
| Biochemistry, Genetics and Molecular Biology | 47 | 18% |
| Medicine and Dentistry | 36 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 7% |
| Chemistry | 16 | 6% |
| Other | 23 | 9% |
| Unknown | 40 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2015.
All research outputs
#6,312,353
of 23,316,003 outputs
Outputs from Nature Reviews Drug Discovery
#1,986
of 3,416 outputs
Outputs of similar age
#73,249
of 307,258 outputs
Outputs of similar age from Nature Reviews Drug Discovery
#21
of 48 outputs
Altmetric has tracked 23,316,003 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 3,416 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.6. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,258 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.